MHA Today | March 27, 2019

March 27, 2019
MHA Today: News for Healthcare Leaders

linkedin twitter facebook
March 27, 2019

MHA Today is provided as a service to members of the Missouri Hospital Association. Additional information is available online at MHAnet.


In This Issue
MHA Releases New Research On The Economic Cost Of The Opioid Crisis
House Passes State Fiscal Year 2020 Budget
Senate Committee Reviews Prescription Drug Monitoring Program Legislation
MHD To Accept Assistant Physician Claims
MHD Makes Alternative Therapies Available To Chronic Pain Patients
HIDI Offers Webinars On New Market Forecaster

Spotlight


MHA Releases New Research On The Economic Cost Of The Opioid Crisis

Staff Contact: Mat Reidhead or Shawn Billings

Policy Brief: Economic Cost of the Opioid Crisis Today, MHA released a new study on the economic cost of the opioid crisis in the U.S.
A similar study from the White House Council of Economic Advisors estimated the cost to be $504 billion, or 2.8 percent of GDP in 2015. Between 2015 and 2017, the number of opioid overdose deaths in the U.S. grew by more than 15,000, or 46 percent, in just two years.

The new study estimates the economic cost of OUD and associated overdose deaths to be $685 billion in 2017, or 3.5 percent of GDP. With a total burden of just more than $14 billion, Missouri was ranked 20th highest in terms of the total cost as a percent of state GDP in 2017, among 50 states and Washington, D.C.

Back To Top

 

Advocate
state and federal health policy developments


House Passes State Fiscal Year 2020 Budget

Staff Contact: Daniel Landon, Rob Monsees or Brian Kinkade

The House of Representatives debated, amended and gave second-round approval to the state fiscal year 2020 budget yesterday. The House endorsed the Budget Committee’s recommendations on issues of concern to hospitals. The House’s budget does not impose hospital-related MO HealthNet reductions. It includes a $10 million appropriation for hospital-related health information technology and Admit Discharge Transfer investments, funding for the Poison Control Center from state sources other than the Federal Reimbursement Allowance, and discrete “line item” funding for the Department of Health and Senior Services to conduct TCD certification reviews. With regard to funding for the Poison Control Center, Representatives soundly defeated an amendment offered by Rep. Deborah Lavender to replace $500,000 GR funding for the program with the FRA. MHA has consistently advocated against this proposed use of the FRA through the House’s budget writing process. The House will give its third and final round approval of the budget before it adjourns for the week on Thursday. The 13 appropriations bills that comprise the state’s budget then will be delivered to the Senate for its review.

Back To Top


Senate Committee Reviews Prescription Drug Monitoring Program Legislation

Staff Contact: Daniel Landon or Bill Anderson

A state Senate committee held a hearing on legislation to create a state-operated prescription drug monitoring program. House Bill 188, sponsored by Rep. Holly Rehder, was passed by the House last month. MHA testified in support of the proposal.

Back To Top


MHD To Accept Assistant Physician Claims

Staff Contact: Brian Kinkade

The MO HealthNet Division will accept claims submitted by assistant physicians under their own National Provider Identifier number for dates of service on and after Jan. 7, 2019. Formerly, the services of assistant physicians were billed through the physician with whom the assistant physician was engaged in collaborative practice. Licensed assistant physicians who wish to bill MHD must enroll as a provider with the Missouri Medicaid Audit and Compliance Unit.

Back To Top


MHD Makes Alternative Therapies Available To Chronic Pain Patients

Staff Contact: Brian Kinkade

Beginning Monday, April 1, the MO HealthNet Division will cover acupuncture, chiropractic therapy, physical therapy and cognitive behavioral therapy for patients with chronic pain diagnoses. These therapies are being added to give primary care physicians alternatives to opioids for the treatment of noncancer-related chronic pain of the neck or back, or chronic pain following a traumatic injury. MHD will offer one-hour webinar training sessions on the limitations and billing requirements for the new services at the following dates and times; advance registration is required.

With the additional services available to treat chronic pain, MHD also will lower its morphine milligram equivalent accumulation limit from 300 MME to 200 MME, effective Thursday, April 4. This limit applies to the combined MME of all of a patient’s prescriptions; MHD’s 90 MME per script limit is unchanged. Exceptions to the 200 MME limit are allowed for patients diagnosed with cancer or sickle cell disease, and patients in palliative or hospice care.

Back To Top

 

HIDI Tech Connect


HIDI Offers Webinars On New Market Forecaster

Staff Contact: Steve Warchol or Cerise Seifert

HIDI is offering a free webinar for hospital staff to learn about the newly developed and released market forecasting tool, Market Optics. The webinar will be presented at 10 a.m. Thursday, March 28, and Friday, March 29, with information on both dates being the same. Registration is available online.

Through Market Optics, hospital team members can access a five-year prediction of their service area and selected service lines. Team members can map, graph and drill-through to market predictions, as well as access their historical market data for the previous five years. All hospitals participating in HIDI’s Missouri Discharge Data Program will have access to the tool at no cost.

Back To Top

 


Consider This ...

The opioid overdose mortality rate in the U.S. has more than doubled throughout the last 10 years. In 2008, 5.9 Americans died from an opioid overdose per 100,000 residents. By 2017 the rate had grown to 14.6, a 10-year, 147 percent increase.

Source: Missouri Hospital Association